Suchergebnisse - (Standardsuche:issn:"1756-8919" OR issn:"1756-8927")

PubPharm (4)

1

Dual FLT3/TOPK inhibitor with activity against FLT3-ITD secondary mutations potently inhibits acute myeloid leukemia cell lines

enthalten in: Future medicinal chemistry | 2018

von Dayal, N. | Opoku-Temeng, C. | Hernandez, D. | +4

2

Aminoisoquinoline benzamides, FLT3 and Src-family kinase inhibitors, potently inhibit proliferation of acute myeloid leukemia cell lines

enthalten in: Future medicinal chemistry | 2017

von Larocque, E. | Naganna, N. | Ma, X. | +5

3

EGFR/HER-targeted therapeutics in ovarian cancer

enthalten in: Future medicinal chemistry | 2012

von Wilken, J. | Badri, T. | Cross, S. | +7

4

Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer

enthalten in: Future medicinal chemistry | 2012

von Gallick, G. | Corn, P. | Zurita, A. | +1

1
[1]